Keytruda PBS for LC

Pharmacy Daily - - News -

MIN­IS­TER for Health Greg Hunt has an­nounced the fund­ing of im­munother­apy medicine Keytruda (pem­brolizumab) for first-line treat­ment of metastatic non-small cell lung can­cer (NSCLC) to take ef­fect 01 Nov.

With­out PBS sub­sidy it would cost over $11,300 per script or $188,000 a year, Hunt said.

This in­di­ca­tion-ex­ten­sion list­ing was rec­om­mended at the Jul 2018 Phar­ma­ceu­ti­cal Ben­e­fits Ad­vi­sory Com­mit­tee (PBAC) meet­ing.

See more at health.gov.au.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.